Insiders · Profile

CELGENE CORP /DE/

10% owner at AGIOS PHARMACEUTICALS · 10% owner at CRISPR Therapeutics. Filing since 24 Oct 2016. CIK 0000816284

Company
Date
Role
Action
Shares
Amount
Of holding
12 Nov 2019
10% owner
Bought
403,225
$12.50M
29.3%
23 Jan 2018
10% owner
Bought
851,154
$57.03M
163%
7 Dec 2017
10% owner
Sold, plan not stated
80,000
$1.54M
1.9%
4 Dec 2017
10% owner
Sold, plan not stated
30,485
$593.54K
0.8%
1 Dec 2017
10% owner
Sold, plan not stated
87,991
$1.68M
2.3%
30 Nov 2017
10% owner
Sold, plan not stated
12,666
$241.16K
0.3%
29 Nov 2017
10% owner
Sold, plan not stated
4,263
$82.06K
0.1%
28 Nov 2017
10% owner
Sold, plan not stated
5,080
$97.64K
0.1%
27 Nov 2017
10% owner
Sold, plan not stated
27,990
$552.80K
0.7%
24 Nov 2017
10% owner
Sold, plan not stated
26,010
$520.20K
0.7%
22 Nov 2017
10% owner
Sold, plan not stated
256,000
$5.06M
6.1%
20 Nov 2017
10% owner
Sold, plan not stated
158,718
$3.02M
3.6%
17 Nov 2017
10% owner
Sold, plan not stated
51,282
$945.64K
1.1%
16 Nov 2017
10% owner
Sold, plan not stated
105,000
$1.93M
2.3%
15 Nov 2017
10% owner
Sold, plan not stated
15,000
$265.05K
0.3%
14 Nov 2017
10% owner
Sold, plan not stated
14,907
$256.25K
0.3%
13 Nov 2017
10% owner
Sold, plan not stated
65,093
$1.16M
1.4%
10 Nov 2017
10% owner
Sold, plan not stated
10,000
$172.80K
0.2%
9 Nov 2017
10% owner
Sold, plan not stated
20,000
$341.60K
0.4%
8 Nov 2017
10% owner
Sold, plan not stated
16,875
$304.76K
0.4%
7 Nov 2017
10% owner
Sold, plan not stated
23,000
$426.42K
0.5%
6 Nov 2017
10% owner
Sold, plan not stated
79,327
$1.50M
1.6%
3 Nov 2017
10% owner
Sold, plan not stated
22,759
$434.70K
0.5%
24 Oct 2016
10% owner
Bought
800,150
$11.20M
19.8%
24 decisions on file.